Financial Personal
Arbutus to Present at H.C. Wainwright 5th Annual Viral Hepatitis Virtual Conference
WARMINSTER, Pa., Oct. 01, 2024 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure fo
Contact Information Read More